University of Vermont

College of Medicine

community medical school

Community Medical School

Designed to share the medical learning experience with our greater community, Community Medical School is a public lecture series featuring relevant topics presented by University of Vermont College of Medicine/University of Vermont Medical Center faculty experienced with delivering scientific information in an engaging, easy-to-understand manner.

Community Medical School is held on the first Tuesday of each month in Carpenter Auditorium in UVM's Given Building from 6:00-7:30 pm, including a Q+A Session.

The Fall 2016 Community Medical School series includes the following presentations:

September 6 - Prostate Cancer: Innovations & Strategies for Reducing Mental and Physical Impact

Scott Perrapato, D.O.Scott Perrapato, D.O., Associate Professor of Surgery, Division of Urology

Explore the latest innovations in the field of prostate cancer, including measures to improve quality of life, genetic and personal risk assessment, early detection, and prediction of best treatments. Review the latest approaches available, inclusing minimally-invasive surgical and radiation therapies, immunotherapy and gene therapy.

October 4 - The State of Opioid Addiction in Vermont: Treatment & Research

Charles MacLean, M.D., Professor of Medicine and Associate Dean for Primary Care; Patricia Fisher, M.D., Assistant Professor of Family Medicine; and Stephen Leffler, M.D., Professor of Surgery and Chief Medical Officer at the UVM Medical Center

A little more than a decade ago, clinicians believed pain was under-recognized and under-treated. Fast-forward to the present when Vermont and other states across the U.S. are struggling to address an opioid addiction epidemic. Panelists will discuss current U.S. and Vermont opiate prescribing and overdose statistics, local prescribing practices, educational program to educate providers and learners about safe prescribing, and research on prescribing and treatment.

November 1 - The Dengue Fever Vaccine: How It Can Help Us Defend Against the Zika Virus

Sean Diehl, Ph.D. and Kristen Pierce, M.D.Sean Diehl, Ph.D., Assistant Professor of Medicine, and Kristen Pierce, M.D., Associate Professor of Medicine and UVM Vaccine Testing Center researchers

The Dengue virus is part of a group of viruses that include Zika. UVM's Vaccine Testing Center, which conducted clinical research integral to the National Institutes of Health's development of a Dengue vaccine, is now poised to help with research and development of the NIH's Zika virus vaccine. Learn about the characteristics and health impact of these viruses, how immune response is studied, along with other details about vaccine development for these viruses.

**Note: LOCATION CHANGED to Sullivan Classroom for Nov. 1 lecture

December 6 - Genomic Medicine in Vermont

Debra Leonard, M.D.Debra Leonard, M.D., Ph.D., Professor and Chair of Pathology and Laboratory Medicine

Targeted cancer treatments can be more effective in treating cancer cells, often in conjunction with traditional therapies. Hear about how UVM is working toward using the complete genetic information of individual patients to inform their health and healthcare, as well as conducting research to ensure this new strategy not only yields better outcomes, but is also cost-effective.

Last modified October 21 2016 04:35 PM